ARMK Stock Analysis: Aramark Holdings | NYSE

Specialty Business Services | NYSE, USA | Market Cap: 14.597m USD | 12M Return: 58.7% | US03852U1060 | Charts, Fundamentals & Technical Analysis

Food Management, Facility Management, Concessions, Corrections
Total Rating 51
Safety 67
Buy Signal 0.94
Restaurants
Sub-Industry Rotation: +17.4
Market Cap: 14.6B
Avg Turnover: 179M
Risk 3d forecast
Volatility28.2%
VaR 5th Pctl4.62%
VaR vs Median-0.54%
Reward TTM
Sharpe Ratio1.68
Rel. Str. IBD84.3
Rel. Str. Peer Group76.4 pctl
Character TTM
Beta0.605
Beta Downside0.617
Hurst Exponent0.392
Choppyness43.6%
Drawdowns 3y
Max DD27.63%
CAGR/Max DD1.02
CAGR/Mean DD4.40
EPS (Earnings per Share) EPS (Earnings per Share) of ARMK over the last years for every Quarter: "2021-09": 0.21, "2021-12": 0.22, "2022-03": 0.22, "2022-06": 0.25, "2022-09": 0.48, "2022-12": 0.41, "2023-03": 0.28, "2023-06": 0.36, "2023-09": 0.64, "2023-12": 0.41, "2024-03": 0.29, "2024-06": 0.31, "2024-09": 0.54, "2024-12": 0.51, "2025-03": 0.34, "2025-06": 0.4, "2025-09": 0.57, "2025-12": 0.51, "2026-03": 0.49, "2026-06": 0.52, "2026-09": 0.78,
EPS CAGR: 11.27%
EPS Trend: 85.7%
Last SUE: 0.85
Qual. Beats: 2
Revenue Revenue of ARMK over the last years for every Quarter: 2021-09: 3551.264, 2021-12: 3948.26, 2022-03: 3860.529, 2022-06: 4127.378, 2022-09: 4390.457, 2022-12: 3913.72, 2023-03: 3916.156, 2023-06: 4053.05, 2023-09: 4901.565, 2023-12: 4407.765, 2024-03: 4199.913, 2024-06: 4376.076, 2024-09: 4416.947, 2024-12: 4552.086, 2025-03: 4279.298, 2025-06: 4626.451, 2025-09: 5048.464, 2025-12: 4831.549, 2026-03: 4907.342, 2026-06: 5057.909, 2026-09: 5293.209,
Rev. CAGR: 5.59%
Rev. Trend: 91.8%
Last SUE: -0.19
Qual. Beats: 0

Warnings

Altman Z'' In Financial Distress Zone
Below Avwap Earnings

Tailwinds

Idiosyncratic Leader
Tailwind
Pullback 52w

Seasonality 11.9 years of data, until 10/2026

Jan +1.7% 9
Feb -0.7% 0
Mar -0.3% 0
Apr -1.5% 4
May +1.3% 0
Jun +0.9% 14
Jul -0.5% 4
Aug +2.3% 4
Sep -2.7% 28
Oct +1.3% 4
Nov +1.4% 0
Dec -1.1% 9

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: ARMK Aramark Holdings

Aramark provides food, beverage, and facilities management services to institutional clients across education, healthcare, business and industry, sports, leisure, and corrections markets in the United States and internationally. The company reports through two segments: Food and Support Services United States and Food and Support Services International.

Its service portfolio includes food and beverage management (dining, catering, convenience retail, concessions, and vending), non-clinical healthcare support (patient nutrition, retail food, environmental services, and procurement), and facility operations (plant maintenance, housekeeping, energy management, grounds keeping, and capital project management). Aramark also delivers specialized services such as correctional food service, commissary and laundry operations, and concessions at sports and entertainment venues.

The company was founded in 1959, is headquartered in Philadelphia, Pennsylvania, and trades on the NYSE under the ticker ARMK following its December 2013 IPO.

Aramark operates under a contract services business model, generating revenue through long-term managed service agreements with institutional clients rather than direct consumer transactions. It is one of the largest global competitors in the contract foodservice sector alongside Compass Group and Sodexo.

Headlines to Watch Out For
  • US food services revenue grows on healthcare and education demand
  • International segment margins pressured by labor and inflation costs
  • Sports and leisure concessions revenue rebounds with live event attendance
  • Debt paydown reduces interest expense and supports capital allocation flexibility
Piotroski VR-10 (Strict) 3.0
Net Income: 433.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.41 > 1.0
NWC/Revenue: -0.08% < 20% (prev -0.13%; Δ 0.05% < -1%)
CFO/TA 0.07 > 3% & CFO 910.8m > Net Income 433.7m
Net Debt (5.12b) to EBITDA (1.46b): 3.52 < 3
Current Ratio: 1.00 > 1.5 & < 3
Outstanding Shares: last quarter (270.3m) vs 12m ago 1.24% < -2%
Gross Margin: 7.52% > 18% (prev 7.69%; Δ -0.17% > 0.5%)
Asset Turnover: 151.0% > 50% (prev 139.1%; Δ 11.90% > 0%)
Interest Coverage Ratio: 2.81 > 6 (EBIT TTM 924.3m / Interest Expense TTM 328.4m)
Altman Z'' 0.94
A: -0.00 (Total Current Assets 3.83b - Total Current Liabilities 3.85b) / Total Assets 13.3b
B: 0.03 (Retained Earnings 453.3m / Total Assets 13.3b)
C: 0.07 (EBIT TTM 924.3m / Avg Total Assets 13.3b)
D: 0.36 (Book Value of Equity 3.49b / Total Liabilities 9.81b)
Altman-Z'' = 0.94 = BB
Beneish M -3.01
DSRI: 0.97 (Receivables 2.35b/2.24b, Revenue 20.1b/18.5b)
GMI: 1.02 (GM 7.69% / 7.52%)
AQI: 0.94 (AQ_t 0.52 / AQ_t-1 0.55)
SGI: 1.09 (Revenue 20.1b / 18.5b)
TATA: -0.04 (NI 433.7m - CFO 910.8m) / TA 13.3b)
Beneish M = -3.01 (Cap -4..+1) = AA
What is the price of ARMK shares?

As of November 19, 2026, the stock is trading at USD 56.58 with a total of 4,775,061 shares traded. Over the past week, the price has changed by +4.35%, over one month by +1.54%, over three months by -8.26% and over the past year by +58.66%.

Current recommended Stop Loss: 54.10 (which is 4.4% or 1.3 ATR below the current price).

Is ARMK a buy, sell or hold?

Aramark Holdings has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy ARMK.

  • StrongBuy: 11
  • Buy: 3
  • Hold: 1
  • Sell: 1
  • StrongSell: 0

What are the forecasts/targets for the ARMK price?
Analysts Target Price 67.5 19.4%
Aramark Holdings (ARMK) - Fundamental Data Overview as of 18 November 2026
Market Cap USD = 14.6b (14.6b USD * 1.0 USD.USD)
P/E Trailing = 34.179
P/E Forward = 20.7469
P/S = 0.7355
P/B = 4.1895
P/EG = 0.8399
Revenue TTM = 20.1b USD
EBIT TTM = 924.3m USD
EBITDA TTM = 1.46b USD
Long Term Debt = 5.37b USD (from longTermDebt, last fiscal year)
Short Term Debt = 100.2m USD (from shortTermDebt, last quarter)
Debt = 5.81b USD (corrected: LT Debt 5.37b + ST Debt 100.2m) + Leases 338.1m
Net Debt = 5.12b USD (calculated: Debt 5.81b - CCE 687.8m)
Enterprise Value = 19.7b USD (14.6b + Debt 5.81b - CCE 687.8m)
Interest Coverage Ratio = 2.81 (Ebit TTM 924.3m / Interest Expense TTM 328.4m)
EV/FCF = 42.15x (Enterprise Value 19.7b / FCF TTM 467.9m)
FCF Yield = 2.37% (FCF TTM 467.9m / Enterprise Value 19.7b)
FCF Margin = 2.33% (FCF TTM 467.9m / Revenue TTM 20.1b)
Net Margin = 2.16% (Net Income TTM 433.7m / Revenue TTM 20.1b)
Gross Margin = 7.52% ((Revenue TTM 20.1b - Cost of Revenue TTM 18.6b) / Revenue TTM)
Gross Margin QoQ = 9.36% (prev 8.51%)
Tobins Q-Ratio = 1.48 (Enterprise Value 19.7b / Total Assets 13.3b)
Interest Expense / Debt = 5.65% (Interest Expense 328.4m / Debt 5.81b)
Taxrate = 26.77% (159.5m / 595.9m)
NOPAT = 676.9m (EBIT 924.3m * (1 - 26.77%))
Current Ratio = 1.00 (Total Current Assets 3.83b / Total Current Liabilities 3.85b)
Debt / Equity = 1.66 (Debt 5.81b / totalStockholderEquity, last quarter 3.49b)
Debt / EBITDA = 3.52 (Net Debt 5.12b / EBITDA 1.46b)
Debt / FCF = 10.95 (Net Debt 5.12b / FCF TTM 467.9m)
Total Stockholder Equity = 3.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.26% (Net Income 433.7m / Total Assets 13.3b)
RoE = 12.97% (Net Income TTM 433.7m / Total Stockholder Equity 3.34b)
RoCE = 10.60% (EBIT 924.3m / Capital Employed (Equity 3.34b + L.T.Debt 5.37b))
RoIC = 7.63% (NOPAT 676.9m / Invested Capital 8.87b)
WACC = 6.67% (E(14.6b)/V(20.4b) * Re(7.68%) + D(5.81b)/V(20.4b) * Rd(5.65%) * (1-Tc(0.27)))
Discount Rate = 7.68% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 33.25 | Cagr: 0.61%
[DCF] Terminal Value 77.97% ; FCFF base≈393.0m ; Y1≈450.6m ; Y5≈663.1m
[DCF] Fair Price = 18.41 (EV 9.98b - Net Debt 5.12b = Equity 4.85b / Shares 263.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 85.71 | EPS CAGR: 11.27% | SUE: 0.85 | # QB: 2
Revenue Correlation: 91.80 | Revenue CAGR: 5.59% | SUE: -0.19 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.62 | Chg30d=-2.32% | Revisions=-17% | Analysts=10
EPS next Quarter (2027-03-31): EPS=0.61 | Chg30d=-1.06% | Revisions=-17% | Analysts=10
EPS current Year (2027-09-30): EPS=2.77 | Chg30d=-1.42% | Revisions=-50% | GrowthEPS=+24.4% | GrowthRev=+9.5%
EPS next Year (2028-09-30): EPS=3.34 | Chg30d=-0.58% | Revisions=-22% | GrowthEPS=+20.4% | GrowthRev=+7.6%
[Analyst] Revisions Ratio: -41% (up=5, down=14)